Skip to main content
. 2019 Jan 17;31(2):180–187. doi: 10.1016/j.joco.2018.12.006

Fig. 2.

Fig. 2

Fine-tuning of therapy in a birdshot retinochoroiditis (BRC) patient where treatment had to be adjusted because of side-effects of ongoing therapy. MYF: Myfortic®, mycophenolic acid. REM: Remicade®, infliximab, anti-TNF-α agent. CsA: cyclosporine. Prograf® = tacrolimus. P: Prednisone. Pink shadowed area accounts for disease evolution and treatment combinations before disease was under control.